Actinium Pharmaceuticals (ATNM)
(Real Time Quote from BATS)
$8.38 USD
-0.28 (-3.23%)
Updated May 23, 2024 12:46 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
Actinium Pharmaceuticals, Inc. [ATNM]
Reports for Purchase
Showing records 61 - 80 ( 91 total )
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare -New Leukemia Approvals - Their Implications
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Dropping Coverage
Provider: H.C. Wainwright & Co., Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare - ORD-ARN-JFK: Crossing Our Onco Radar
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Antibody, Radiolabel, Action! Resuming with Buy and $6 PT
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Brave New World of AML
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
We are transferring coverage of ATNM to Director of Research Jeff Martin and placing shares Under Review
Provider: Roth Capital Partners, Inc.